Peak Bio, Inc.

Peak Bio, Inc., trading under the ticker IGNY, is a clinical-stage biopharmaceutical company that resulted from a business combination with Ignyte Acquisition Corp, a blank-check company sponsored by Ignyte Sponsor LLC that completed its initial public offering in 2021. Focused on the life sciences and biopharmaceutical sector, the combined company filed a Form 10-Q with the Securities and Exchange Commission on August 15, 2022, reflecting its post-merger operating status as a publicly listed entity. The accession number on record is 0001193125-22-221339. For complete filing histories, sponsor profiles, and SPAC deal analytics on IGNY and hundreds of other transactions, sign up for full data access at SpacDesk.